financetom
Market
financetom
/
Market
/
Steel Stocks Rebound: JPMorgan Lifts Ratings On Nucor, Steel Dynamics, US Steel
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Steel Stocks Rebound: JPMorgan Lifts Ratings On Nucor, Steel Dynamics, US Steel
Sep 10, 2024 3:44 PM

Following the pressure on shares of North America steel companies due to weakening fundamentals, they are now more attractively valued.

North American steel equities are now better positioned, with a potential improvement in the rate environment ahead and a stable post-election backdrop in 2025, according to JPMorgan.

Analyst Bill Peterson upgraded the ratings for:

Nucor Corp ( NUE ) from Neutral to Overweight, while raising the price target from $170 to $174.

Steel Dynamics Inc ( STLD ) from Underweight to Neutral, while lifting the price target from $120 to $131.

United States Steel Corporation ( X ) from Neutral to Overweight, while raising the price target from $40 to $42.

Check out other analyst stock ratings.

Nucor ( NUE ), Steel Dynamics ( STLD ) and US Steel are likely to provide "timid outlook comments" next week, due to "lower lagged-contract pricing and hand-to-mouth buying more than offsetting easing scrap costs," Peterson said in a note.

Uncertainties related to Fed rates and election results are likely to be "a key overhang" on demand in the back half of the year, "likely resulting in further de-risking of consensus estimates," the analyst wrote.

Nucor ( NUE ) and United States Steel ( X ) are the best positioned for upside going into next year, according to Peterson. While both Nucor ( NUE ) and Steel Dynamics ( STLD ) have "strong product diversification," Peterson noted that the recent pullback in United States Steel’s stock offers "an attractive buying opportunity on standalone valuation support."

Price action at the time of publication Monday:

Nucor's ( NUE ) shares had climbed by 2.95% to $142.89

Shares of Steel Dynamics ( STLD ) had risen by 1.22% to $112.35

United States Steel's ( X ) stock had jumped by 4.00% to $32.52

Read Next:

US Yield Curve No Longer Inverted: Why This Time The Recession Scenario Might Be Different For Investors

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exchange-Traded Funds Higher, US Equities Mixed After Midday Trading
Exchange-Traded Funds Higher, US Equities Mixed After Midday Trading
Jan 16, 2025
01:15 PM EST, 01/16/2025 (MT Newswires) -- Broad Market Indicators Broad-market exchange-traded funds IWM and IVV rose. Actively traded Invesco QQQ Trust (QQQ) fell 0.1%. US equity indexes were mixed in choppy midday trading Thursday as retail sales grew less than expected in December and quarterly earnings season got underway. Energy iShares US Energy ETF (IYE) and Energy Select Sector...
US Equity Indexes Mixed as Retail Sales Growth Slows, Q4 Earnings Begin Rolling
US Equity Indexes Mixed as Retail Sales Growth Slows, Q4 Earnings Begin Rolling
Jan 16, 2025
12:55 PM EST, 01/16/2025 (MT Newswires) -- US equity indexes were mixed in choppy trading on Thursday after retail sales growth slowed by half in December and Q4 earnings season began to pick up steam. The Nasdaq Composite fell 0.2% to 19,472.6. The Dow Jones Industrial Average rose less than 0.1% to 43,250.5. The S&P 500 climbed 0.1% to 5,957.9...
Top Midday Gainers
Top Midday Gainers
Jan 16, 2025
01:01 PM EST, 01/16/2025 (MT Newswires) -- Biomerica ( BMRA ) said Thursday that the United Arab Emirates Ministry of Health and Prevention approved its Fortel prostate-specific antigen screening test for detection of prostate cancer. Shares more than doubled as intraday trading volume surged to over 353 million from a daily average of about 955,000. Flexible Solutions International ( FSI...
Top Midday Decliners
Top Midday Decliners
Jan 16, 2025
01:31 PM EST, 01/16/2025 (MT Newswires) -- Atara Biotherapeutics ( ATRA ) reported compliance issues on Thursday involving a third-party manufacturing facility for Ebvallo, a treatment for patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease. Shares slumped 37% as intraday trading volume catapulted to over 1.8 million million versus a daily average of about 127,000. Silexion Therapeutics ( SLXN ) shares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved